Related Experiment Videos
Molecular heterogeneity underlying the G6PD Mediterranean phenotype
C M Corcoran1, V Calabrò, G Tamagnini
1Department of Haematology, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.
Human Genetics
|March 1, 1992
Summary
Researchers identified a new genetic variant, G6PD Coimbra, causing glucose-6-phosphate dehydrogenase deficiency. This discovery aids in understanding the molecular basis of this common enzyme disorder.
Area of Science:
- Genetics
- Biochemistry
- Molecular Biology
Background:
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common inherited red blood cell disorder.
- Favism, a condition triggered by certain foods or drugs, is associated with G6PD deficiency.
- Understanding the molecular basis of G6PD variants is crucial for diagnosis and management.
Purpose of the Study:
- To define the molecular basis of a novel glucose-6-phosphate dehydrogenase (G6PD) deficiency variant.
- To investigate a Portuguese patient with a family history of favism and G6PD deficiency.
Main Methods:
- Polymerase chain reaction (PCR) amplification and gene sequencing were used to analyze the G6PD gene.
- Single-strand conformation polymorphism (SSCP) analysis was employed to detect DNA variations.
- Biochemical properties of red-cell G6PD were compared to known variants.
Main Results:
- A novel C-T transition at nucleotide 592 in exon VI of the G6PD gene was identified.
- This mutation results in an arginine to cysteine substitution, 10 amino acids downstream from the G6PD Mediterranean mutation.
- The same mutation was confirmed in a G6PD-deficient patient from Southern Italy.
- The new variant was named G6PD Coimbra.
Conclusions:
- G6PD Coimbra represents a new molecular variant of glucose-6-phosphate dehydrogenase deficiency.
- This finding expands the spectrum of known G6PD mutations.
- Further research into G6PD Coimbra may elucidate its specific biochemical and clinical characteristics.